Below are a series of postings that discuss different aspects of FLC research. Please click on any of the links below to learn more!
- Immunotherapy roadmap and activities
A new era in cancer therapy dawned in 2011 when the FDA approved ipilimumab (Yervoy) to treat metastatic melanoma. This was the first of a novel class of drugs called immune checkpoint inhibitors (ICIs), which … - Attacking the metabolism of FLC
“You are what you eat” is a phrase popularized by the American nutritionist Victor Lindlahr in the 1930s. Of course, the body’s cells have no way to determine whether the nutrients that reach them come … - Perspectives on FLC immunotherapyBelow is a discussion of the implications of recent research efforts on future FLC immunotherapy treatments as summarized by Mark Furth …
